Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710.

Christodouleas JP, Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Tangen CM, Lerner SP, Guzzo TJ, Malkowicz SB, Herr H.

Cancer. 2014 Apr 15;120(8):1272-80. doi: 10.1002/cncr.28544. Epub 2014 Jan 3. Erratum in: Cancer. 2015 Jan 1;121(1):162. Herr, Harry [added].

2.

A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.

Baumann BC, Guzzo TJ, He J, Keefe SM, Tucker K, Bekelman JE, Hwang WT, Vaughn DJ, Malkowicz SB, Christodouleas JP.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):81-8. doi: 10.1016/j.ijrobp.2012.03.007. Epub 2012 Apr 28.

PMID:
22543204
3.

Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.

Baumann BC, Guzzo TJ, He J, Vaughn DJ, Keefe SM, Vapiwala N, Deville C, Bekelman JE, Tucker K, Hwang WT, Malkowicz SB, Christodouleas JP.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):363-9. doi: 10.1016/j.ijrobp.2012.03.061. Epub 2012 May 30.

PMID:
22658217
4.

Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.

Reddy AV, Pariser JJ, Pearce SM, Weichselbaum RR, Smith ND, Steinberg GD, Liauw SL.

Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1031-9. doi: 10.1016/j.ijrobp.2015.10.051. Epub 2015 Nov 5.

PMID:
27026309
5.

Risk prediction models of locoregional failure after radical cystectomy for urothelial carcinoma: external validation in a cohort of korean patients.

Ku JH, Kim M, Jeong CW, Kwak C, Kim HH.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1032-7. doi: 10.1016/j.ijrobp.2014.04.049. Epub 2014 Jul 8.

PMID:
25035206
6.

Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer.

Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Herr HW, Lerner SP, Guzzo TJ, Malkowicz SB, Christodouleas JP.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):703-6. doi: 10.1016/j.ijrobp.2016.01.034. Epub 2016 Jan 23.

7.

Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.

Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.

Eur Urol. 2013 Sep;64(3):465-71. doi: 10.1016/j.eururo.2013.03.043. Epub 2013 Apr 3.

PMID:
23571005
9.

Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.

Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF.

Eur Urol. 2013 Nov;64(5):837-45. doi: 10.1016/j.eururo.2012.07.026. Epub 2012 Jul 20.

PMID:
22877503
10.

Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.

Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF.

BJU Int. 2011 Sep;108(5):687-92. doi: 10.1111/j.1464-410X.2010.09902.x. Epub 2010 Nov 19.

11.

Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.

Novotny V, Froehner M, May M, Protzel C, Hergenröther K, Rink M, Chun FK, Fisch M, Roghmann F, Palisaar RJ, Noldus J, Gierth M, Fritsche HM, Burger M, Sikic D, Keck B, Wullich B, Nuhn P, Buchner A, Stief CG, Vallo S, Bartsch G, Haferkamp A, Bastian PJ, Hakenberg OW, Propping S, Aziz A.

World J Urol. 2015 Nov;33(11):1753-61. doi: 10.1007/s00345-015-1502-y. Epub 2015 Feb 8.

PMID:
25663359
12.

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.

J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422.

PMID:
17085118
13.

Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.

Yuh B, Wilson T, Bochner B, Chan K, Palou J, Stenzl A, Montorsi F, Thalmann G, Guru K, Catto JW, Wiklund PN, Novara G.

Eur Urol. 2015 Mar;67(3):402-22. doi: 10.1016/j.eururo.2014.12.008. Epub 2015 Jan 2. Review.

PMID:
25560797
14.
15.

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Cancer. 2000 May 15;88(10):2326-32.

PMID:
10820355
16.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
17.

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG.

J Clin Oncol. 2001 Feb 1;19(3):666-75.

PMID:
11157016
18.

Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.

Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M.

Eur Urol. 2013 Feb;63(2):371-8. doi: 10.1016/j.eururo.2012.06.008. Epub 2012 Jun 16.

PMID:
22727174
19.

Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.

Hugen CM, Polcari AJ, Fitzgerald MP, Dauw C, Flanigan RC, Quek ML.

J Surg Oncol. 2010 Sep 15;102(4):334-7. doi: 10.1002/jso.21642.

PMID:
20607757
20.

Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.

J Urol. 2007 Dec;178(6):2308-12; discussion 2313. Epub 2007 Oct 22.

PMID:
17936804

Supplemental Content

Support Center